Fludarabine monophosphate en es it fr

Fludarabine monophosphate Brand names, Fludarabine monophosphate Analogs

Fludarabine monophosphate Brand Names Mixture

  • No information avaliable

Fludarabine monophosphate Chemical_Formula

C10H13FN5O7P

Fludarabine monophosphate RX_link

http://www.rxlist.com/cgi/generic/fludarabine.htm

Fludarabine monophosphate fda sheet

Fludarabine_monophosphate FDA

Fludarabine monophosphate msds (material safety sheet)

Fludarabine_monophosphate MSDS

Fludarabine monophosphate Synthesis Reference

J. A. Montgomery, U.S. pat. 4,210,745 (1980 to U.S. Dept. Health, Education and Welfare)

Fludarabine monophosphate Molecular Weight

365.212 g/mol

Fludarabine monophosphate Melting Point

260 oC

Fludarabine monophosphate H2O Solubility

3.53 mg/ml

Fludarabine monophosphate State

Solid

Fludarabine monophosphate LogP

-0.852

Fludarabine monophosphate Dosage Forms

Tablet; Powder for solution; IV solution

Fludarabine monophosphate Indication

For the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen

Fludarabine monophosphate Pharmacology

Fludarabine is a chemotherapy drug used in the treatment of chronic lymphocytic leukemia. It acts at DNA polymerase alpha, ribonucleotide reductase and DNA primase, results in the inhibition of DNA synthesis, and destroys the cancer cells.

Fludarabine monophosphate Absorption

No information avaliable

Fludarabine monophosphate side effects and Toxicity

No information avaliable

Fludarabine monophosphate Patient Information

Fludarabine monophosphate Organisms Affected

Humans and other mammals